17
Participants
Start Date
December 31, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2025
Toripalimab
200mg q2w intravenous
Actinomycin-D
1.25mg/m2，2mg max dose, q2w, intravenous
RECRUITING
Peking Union Medical College Hospital, Beijing
Obstetrics & Gynecology Hospital of Fudan University
OTHER
Shengjing Hospital
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Henan Cancer Hospital
OTHER_GOV
Gansu Provincial Maternal and Child Health Care Hospital
OTHER
Dalian Maternity and Child Care Hospital
OTHER
The First Affiliated Hospital of Xiamen University
OTHER
Sichuan Cancer Hospital and Research Institute
OTHER
Shanghai Junshi Bioscience Co., Ltd.
OTHER
Peking Union Medical College Hospital
OTHER